Exploratory Clinical Trial to Evaluate the Efficacy and Safety of Lumbar Cervical Interforaminal Epidural Nerve Block Using the Navigation Plus System, A Randomized, Single-blind, Single-center, Prospective trial (Investigator-initiated)

Korea University Anam Hospital0 个研究点目标入组 28 人开始时间: 待定最近更新: 2024年4月2日

适应症

试验速览

暂无简介。

•1) Age 20 years or older
•2) Neurological symptoms such as low back pain or unilateral lower extremity radicular pain due to adhesions or inflammation in the anterior epidural space of the lumbar spine based on imaging examination (CT or MRI) and physical examination. However, they do not show symptoms of paralysis or sensory loss.
•3) Voluntarily agree to participate in the clinical trial and provide written informed consent.

•1) blood coagulation disorder (INR > 1.5 or platelet count < 100,000/cm2 ) or taking anticoagulants
•2) Have a systemic or injection site infection
•3) Allergic to any medication (contrast, local anesthetic, steroids)
•4) Allergic to adhesives (adhesives)
•5) Pregnant or lactating women
•6) Have difficulty prone position
•7) Those who are considered for surgical treatment due to neurological impairment
•8) Those who are unable to complete pain assessments or questionnaires for the study due to cognitive decline
•9) Participation in other clinical trials within 1 month of the screening date
•10) Other conditions that, in the opinion of the investigator, make participation in the study inappropriate.

发起方